SEC Filings

Hero overlay Cancer research Analyst Coverage Annual Report Proxy Materials Corporate Governance Events Presentations Financial Information Investor Disclaimer Press Releases Stock Information
Filing date Form Description View
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

View HTML
8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
8-K/A

Amendment to a previously filed 8-K

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
D

Notice of Exempt Offering of Securities

View HTML
8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
3

Initial filing by director officer or owner of more than ten percent

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
S-3ASR

S-3ASR

View HTML

Data provided by Kaleidoscope.

Investor Contact

Pacific Biosciences of California, Inc.
1305 O’Brien Drive, Menlo Park, CA 94025
ir@pacb.com